Complete Response of Metastatic Melanoma to Second Line Chemotherapy with Paclitaxel and Carboplatin - Case Report
Abstract
Objective. We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.
Case report. Metastatic melanoma is an aggressive cancer with poor prognosis and 10 year survival less than 10%. We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.
Conclusion. Second line chemotherapy with paclitaxel and carboplatin in the treatment of metastatic melanoma may yield effective results.
Keywords
Full Text:
PDFDOI: http://dx.doi.org/10.5644/ama2006-124.217
Refbacks
- There are currently no refbacks.